Viewing Study NCT05824494


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-26 @ 12:05 AM
Study NCT ID: NCT05824494
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-05-06
First Post: 2023-04-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors
Sponsor: Women's Hospital School Of Medicine Zhejiang University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module